Medistep Healthcare IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Fri Aug 08 2025
The Medistep Healthcare IPO GMP is ₹17 as of 8th August 2025. It is a bookbuilding IPO of ₹16.10 crores and comprising a fresh issue of 37.44 lakh shares. The issue will be listed on NSE and SME on its tentative listing date, 18th August 2025. The face value of Medistep Healthcare shares stands at ₹10 per share, and the IPO price is set at ₹43 per share. Retail investors can bid for a minimum of 2 lots of 6,000 shares worth ₹2,58,000.
Medistep Healthcare IPO GMP Grey Market Premium
As of 8th August 2025, Medistep Healthcare IPO GMP stands at ₹17 per share. Thus, the estimated listing price would be ₹60. This indicates that the estimated listing gain in this IPO could be 39.53%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Medistep Healthcare IPO GMP updates.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 08-08-2025 | ₹43.00 | ₹17.00 | ₹60.00 | 39.53% |
| 07-08-2025 | ₹43.00 | ₹17.00 | ₹60.00 | 39.53% |
| 06-08-2025 | ₹43.00 | ₹12.00 | ₹55.00 | 27.91% |
| 05-08-2025 | ₹43.00 | ₹12.00 | ₹55.00 | 27.91% |
Medistep Healthcare IPO Details
| IPO Open Date | 8th August 2025 |
| IPO Close Date | 12th August 2025 |
| IPO Allotment Date | 13th August 2025 |
| Refund Initiation | 14th August 2025 |
| Issue Size | 37,44,000 shares(aggregating up to ₹16.10 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 3,000 Shares |
| Issue Price Band | ₹43 per share |
| Issue Type | Fixed Price IPO |
| Listing At | NSE & SME |
| Listing Date | 18th August 2025 |
Explanation
Medistep Healthcare IPO: Medistep Healthcare Limited has declared an issue price of ₹43 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 6,000 shares worth ₹2,58,000. The face value of Medistep Healthcare Limited shares is ₹10 per share. The shares of Medistep Healthcare Limited will be listed on NSE and SME on its tentative listing day, 18th August 2025. Scroll down to check GMP updates and Medistep Healthcare IPO reviews.
Objectives of the Medistep Healthcare IPO
The primary aim of the Medistep Healthcare IPO is to raise ₹16.10 crores. On the other hand, Medistep Healthcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Medistep Healthcare IPO.
- To meet the general corporate purpose.
- To prepayment or repayment of borrowings availed by the company.
- To meet the general corporate requirements.
- Funding the capital expenditure towards the purchase of plant and machinery for expansion at the existing facility.
Medistep Healthcare IPO Registrar
Cameo Corporate Services Limited is the registrar of the Medistep Healthcare IPO, waiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Medistep Healthcare allotment and refund, you can contact Cameo Corporate Services Limited at cameo@cameoindia.com or +91-44-28460390.
Medistep Healthcare IPO Review
The Medistep Healthcare IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Medistep Healthcare Limited’s revenue increased by 27% from ₹39.08 crores in March 2024 to ₹49.66 crores in March 2025. Moreover, the company’s PAT increased by 25% from ₹3.33 crores to ₹4.14 crores. Investors can analyse other relevant factors and make a decision accordingly.
Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Medistep Healthcare IPO or not.
Medistep Healthcare Limited Technicals
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 10.86 |
| EPS (Earnings Per Share) | 3.96 |
| RoNW | 29.06% |
| ROCE | 38.91% |
| ROE | 29.06% |
| EBITDA Margin | 11.27% |
| Price to Book Value | 2.67 |
| Market Capitalisation | ₹61.10 Cr |
The PE ratio of Medistep Healthcare Limited shares is 10.86, and its Earnings Per Share (EPS) stands at 3.96. Thus, the Medistep Healthcare IPO can potentially deliver gains on its tentative listing date, 18th August 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Medistep Healthcare Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 10.86 | 14.74 |
| EPS | 3.96 | 2.92 |
Medistep Healthcare Peer Comparison
| Company Name | EPS | P/E Ratio | RoNW | Face value | Revenue |
| Medistep Healthcare Limited | 3.96 | 10.86 | 24.62 | ₹10 | 31.63 |
| Fabino Enterprises Limited | 0.29 | 89.86 | 3.12 | ₹10 | 21.39 |
| Achyut Healthcare Limited | 0.02 | 200.50 | 1.77 | ₹1 | 6.86 |
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Also Read : Knowledge Realty Trust REIT IPO GMP & Review: Apply or Avoid?
FAQs on Medistep Healthcare IPO
What is the Medistep Healthcare IPO GMP?
Ans. Currently, on 8th August 2025, the Medistep Healthcare IPO GMP (Grey Market Premium) stands at ₹17. This indicates that the estimated listing price could be ₹60 per share.
What is the issue price of the Medistep Healthcare IPO?
Ans. The Medistep Healthcare IPO price is set at ₹43 per share. Retail investors can apply for a minimum of 2 lots consisting of 6,000 shares worth ₹2,58,000. Moreover, HNIs are required to bid for a minimum of 3 lots (9,000 shares) worth ₹3,87,000.
Who is the registrar of the Medistep Healthcare IPO?
Ans. Cameo Corporate Services Limited is the registrar of the Medistep Healthcare IPO, waiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Medistep Healthcare allotment and refund, you can contact Cameo Corporate Services Limited at cameo@cameoindia.com or +91-44-28460390.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Medistep Healthcare IPO, download the Medistep Healthcare IPO RHP and Medistep Healthcare IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Essex Marine IPO GMP & Review: Apply or Avoid?
BLT Logistics IPO GMP & Review: Apply or Avoid?
RR Kabel Q1 Results FY26: Q1 PAT Jumps 39.44% to ₹89.77 Crore; Revenue Surged 13.85% YoY
Kirlosker Brothers Q1 Results FY26: Q1 PAT Soars 2.46% to ₹66.70 Crore; Revenue Declined 5.03% YoY
Aaradhya Disposal IPO GMP & Review: Apply or Avoid?
Aarti Industries Q1 Results FY26: Q1 PAT Down 68.61% to ₹43.00 Crore; Revenue Declined 9.45% YoY
